You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
9 October 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Friday that the US Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab ...
9 October 2026 - Clinical-stage biotechnology company Alpheus Medical Inc announced on Thursday the launch of a new clinical trial evaluating its investigational Porphyrin Metabolite Activation (PoMA) therapy in patients with butterfly glioblastoma (...
9 October 2026 - Sophos IRB Inc, an independent, oncology-focused central institutional review board, announced on Thursday a strategic partnership with the Addario Lung Cancer Medical Institute (ALCMI), an international nonprofit specialising in inv...
9 October 2026 - Northwest Biotherapeutics (NWBio) (OTCQB:NWBO), a biotechnology company developing DCVax personalised immune therapies for solid tumour cancers, announced on Thursday a collaboration with the UK National Health Service Blood and Tran...
8 October 2026 - European immunology company argenx SE (EBR & NASDAQ: ARGX) on Thursday reported positive top-line results from a Phase 2 study of FB102, a first-in-class CD122 inhibitor, in adults with coeliac disease.FB102 achieved a statistica...
8 October 2026 - Clinical-stage biopharmaceutical company Vir Biotechnology Inc (Nasdaq:VIR) announced on Thursday that the US Food and Drug Administration (FDA) has granted Fast Track designation to VIR-5500, a PSMA-targeted PRO-XTEN dual-masked T-c...
8 October 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Thursday that the US Food and Drug Administration (FDA) has accepted its supplemental New Drug Application for KERENDIA (finerenone) for adults w...